Search Results - "Hyland, Keith"

Refine Results
  1. 1

    Clinical Utility of Monoamine Neurotransmitter Metabolite Analysis in Cerebrospinal Fluid by Hyland, Keith

    Published in Clinical chemistry (Baltimore, Md.) (01-04-2008)
    “…Measurements of monoamine neurotransmitters and their metabolites in plasma and urine are commonly used to aid in the detection and monitoring of neuroblastoma…”
    Get full text
    Journal Article
  2. 2

    Inherited disorders affecting dopamine and serotonin: critical neurotransmitters derived from aromatic amino acids by Hyland, Keith

    Published in The Journal of nutrition (01-06-2007)
    “…Many inherited disorders affecting aromatic amino acid metabolism have been described. This review will concentrate on the defects that lead to deficiencies of…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Case report: discovery of 2 gene variants for aromatic L-amino acid decarboxylase deficiency in 2 African American siblings by Monteleone, Berrin, Hyland, Keith

    Published in BMC neurology (09-01-2020)
    “…Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare genetic disorder with heterogeneous phenotypic spectrum resulting from disease-causing variants…”
    Get full text
    Journal Article
  5. 5

    Cerebral folate deficiency by Hyland, Keith, Shoffner, John, Heales, Simon J

    Published in Journal of inherited metabolic disease (01-10-2010)
    “…Cerebral folate deficiency (CFD) is defined as any neurological syndrome associated with a low cerebrospinal fluid (CSF) concentration of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Identification of a novel biomarker for pyridoxine‐dependent epilepsy: Implications for newborn screening by Wempe, Michael F., Kumar, Amit, Kumar, Vijay, Choi, Yu J., Swanson, Michael A., Friederich, Marisa W., Hyland, Keith, Yue, Wyatt W., Van Hove, Johan L. K., Coughlin, Curtis R.

    Published in Journal of inherited metabolic disease (01-05-2019)
    “…Pyridoxine‐dependent epilepsy (PDE) is often characterized as an early onset epileptic encephalopathy with dramatic clinical improvement following pyridoxine…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Altered serotonin, dopamine and norepinepherine levels in 15q duplication and Angelman syndrome mouse models by Farook, M Febin, DeCuypere, Michael, Hyland, Keith, Takumi, Toru, LeDoux, Mark S, Reiter, Lawrence T

    Published in PloS one (16-08-2012)
    “…Childhood neurodevelopmental disorders like Angelman syndrome and autism may be the result of underlying defects in neuronal plasticity and ongoing problems…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Exploratory study of the effect of one week of orally administered CNSA-001 (sepiapterin) on CNS levels of tetrahydrobiopterin, dihydrobiopterin and monoamine neurotransmitter metabolites in healthy volunteers by Smith, Neil, Longo, Nicola, Levert, Keith, Hyland, Keith, Blau, Nenad

    Published in Molecular genetics and metabolism reports (01-12-2019)
    “…Tetrahydrobiopterin (BH4) is a cofactor for the enzymes tyrosine hydroxylase and tryptophan hydroxylase, the rate-limiting enzymes in the production of the…”
    Get full text
    Journal Article
  13. 13

    Intermittent neurologic decompensation: An underrecognized presentation of tyrosine hydroxylase deficiency by Champagne, Marjolaine, Horvath, Gabriella A., Perreault, Sébastien, Gauthier, Julie, Hyland, Keith, Soucy, Jean‐François, Mitchell, Grant A.

    Published in JIMD reports (01-09-2022)
    “…Tyrosine hydroxylase deficiency (THD) is a treatable inborn error of dopamine biosynthesis caused by mutations in TH. Two presentations are described. Type A,…”
    Get full text
    Journal Article
  14. 14

    The lumbar puncture for diagnosis of pediatric neurotransmitter diseases by Hyland, Keith

    Published in Annals of neurology (2003)
    “…The investigation of infants and children with suspected pediatric neurotransmitter diseases affecting serotonin and catecholamine metabolism is complicated…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    Severe 5,10-Methylenetetrahydrofolate Reductase Deficiency and Two MTHFR Variants in an Adolescent With Progressive Myoclonic Epilepsy by D'Aco, Kristin E., MD, Bearden, David, MD, Watkins, David, PhD, Hyland, Keith, PhD, Rosenblatt, David S., MD, Ficicioglu, Can, MD, PhD

    Published in Pediatric neurology (01-08-2014)
    “…Abstract Background 5,10-Methylenetetrahydrofolate reductase (MTHFR) deficiency is an inborn error of the folate-recycling pathway that affects the…”
    Get full text
    Journal Article
  16. 16

    Seizures With Decreased Levels of Pyridoxal Phosphate in Cerebrospinal Fluid by Goyal, Monisha, MD, Fequiere, Pierre R., MD, McGrath, Tony M., MD, Hyland, Keith, PhD

    Published in Pediatric neurology (01-03-2013)
    “…Abstract Although pyridoxine-dependent seizures have been reported for decades, pyridoxamine phosphate oxidase deficiency has only been recently described…”
    Get full text
    Journal Article
  17. 17

    Serotonin Metabolites in the Cerebrospinal Fluid in Sudden Infant Death Syndrome by Rognum, Ingvar J, Tran, Hoa, Haas, Elisabeth A, Hyland, Keith, Paterson, David S, Haynes, Robin L, Broadbelt, Kevin G, Harty, Brian J, Mena, Othon, Krous, Henry F, Kinney, Hannah C

    “…ABSTRACTForensic biomarkers are needed in sudden infant death syndrome (SIDS) to help identify this group among other sudden unexpected deaths in infancy…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Prevalence of Aromatic l-Amino Acid Decarboxylase Deficiency in At-Risk Populations by Hyland, Keith, Reott, Michael

    Published in Pediatric neurology (01-05-2020)
    “…Aromatic l-amino acid decarboxylase (AADC) deficiency is an autosomal recessive metabolic disorder that results from disease-causing pathogenic variants of the…”
    Get full text
    Journal Article